To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer
To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer
Recruiting · NCT06808412 · Registry updated 2025-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer | Rcctal Cancer | Recruiting | Phase 2 | 2025-02-05 | NCT06808412 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| xiaohua li | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Xijing Hospital | Xi'an | China | 46 |